CR20170601A - PHARMACEUTICAL FORMULATIONS THAT INCLUDE TENOFOVIR AND EMTRICITABINA - Google Patents
PHARMACEUTICAL FORMULATIONS THAT INCLUDE TENOFOVIR AND EMTRICITABINAInfo
- Publication number
- CR20170601A CR20170601A CR20170601A CR20170601A CR20170601A CR 20170601 A CR20170601 A CR 20170601A CR 20170601 A CR20170601 A CR 20170601A CR 20170601 A CR20170601 A CR 20170601A CR 20170601 A CR20170601 A CR 20170601A
- Authority
- CR
- Costa Rica
- Prior art keywords
- emtricitabina
- pharmaceutical formulations
- include tenofovir
- tenofovir
- pharmaceutically acceptable
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229960004556 tenofovir Drugs 0.000 title 1
- SGOIRFVFHAKUTI-ZCFIWIBFSA-N tenofovir (anhydrous) Chemical compound N1=CN=C2N(C[C@@H](C)OCP(O)(O)=O)C=NC2=C1N SGOIRFVFHAKUTI-ZCFIWIBFSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- XQSPYNMVSIKCOC-NTSWFWBYSA-N Emtricitabine Chemical compound C1=C(F)C(N)=NC(=O)N1[C@H]1O[C@@H](CO)SC1 XQSPYNMVSIKCOC-NTSWFWBYSA-N 0.000 abstract 1
- 229960000366 emtricitabine Drugs 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- LDEKQSIMHVQZJK-CAQYMETFSA-N tenofovir alafenamide Chemical compound O([P@@](=O)(CO[C@H](C)CN1C2=NC=NC(N)=C2N=C1)N[C@@H](C)C(=O)OC(C)C)C1=CC=CC=C1 LDEKQSIMHVQZJK-CAQYMETFSA-N 0.000 abstract 1
- 229960004946 tenofovir alafenamide Drugs 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
La invención proporciona una forma de dosificación oral sólida que comprende alafenamida de tenofovir o una sal farmacéuticamente aceptable de la misma, y emtricitabina o una sal farmacéuticamente aceptable de la misma.The invention provides a solid oral dosage form comprising tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562187113P | 2015-06-30 | 2015-06-30 | |
| US201662298373P | 2016-02-22 | 2016-02-22 | |
| US201662317286P | 2016-04-01 | 2016-04-01 | |
| PCT/US2016/040158 WO2017004244A1 (en) | 2015-06-30 | 2016-06-29 | Pharmaceutical formulations comprising tenofovir and emtricitabine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20170601A true CR20170601A (en) | 2018-02-28 |
Family
ID=61730529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20170601A CR20170601A (en) | 2015-06-30 | 2016-06-29 | PHARMACEUTICAL FORMULATIONS THAT INCLUDE TENOFOVIR AND EMTRICITABINA |
Country Status (1)
| Country | Link |
|---|---|
| CR (1) | CR20170601A (en) |
-
2016
- 2016-06-29 CR CR20170601A patent/CR20170601A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017013293A2 (en) | Pharmaceutical formulations comprising tenofovir and emtricitabine | |
| IL264210A (en) | High-dose cannabinoid dosage forms for oral administration | |
| MX2017016802A (en) | Pharmaceutical formulations. | |
| EP4045480A4 (en) | PHARMACEUTICAL FORMULATIONS | |
| IL258464A (en) | Pharmaceutical formulations for the oral delivery of peptide drugs | |
| IL264065A (en) | Gastro-alternate formulations for oral administration and their uses | |
| EP3541385A4 (en) | PHARMACEUTICAL FORMULATIONS | |
| PH12016501841A1 (en) | Immunosuppressant formulation | |
| HUP1700253A1 (en) | Solid preparations for oral administration | |
| MA55015A (en) | PHARMACEUTICAL FORMULATIONS | |
| ZA202006570B (en) | Pharmaceutical formulations | |
| EP3383397A4 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING DORAVIRIN, TENOFOVIR DISOPROXIL FUMARATE AND LAMIVUDINE | |
| PL3326619T3 (en) | Solid oral pharmaceutical compositions comprising tenofovir and emtricitabine | |
| EP3746080A4 (en) | PHARMACEUTICAL FORMULATIONS | |
| MX385513B (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING SAFINAMIDE. | |
| SG11202010792TA (en) | Improved pharmaceutical formulations | |
| EP3697393A4 (en) | PHARMACEUTICAL DOSAGE FORMS | |
| EP3651800C0 (en) | HYPERCOMPRESSED PHARMACEUTICAL FORMULATIONS | |
| CR20170601A (en) | PHARMACEUTICAL FORMULATIONS THAT INCLUDE TENOFOVIR AND EMTRICITABINA | |
| JOP20170198A1 (en) | Pharmaceutical formulations comprising tenofovir and emtricitabine | |
| HUE056233T2 (en) | Ibuprofen preparations for direct oral administration | |
| CY1123966T1 (en) | PROCESS FOR THE PREPARATION OF ENHANCED STABILITY EPOPROSTENOL SODIUM | |
| HK40119321A (en) | Pharmaceutical formulations comprising tenofovir and emtricitabine | |
| TR201721065A2 (en) | Lyophilized pharmaceutical formulations comprising dexmedetomidine | |
| MA41643A (en) | BRUTON TYROSINE KINASE INHIBITOR PHARMACEUTICAL FORMULATIONS |